Skip to main content
Livermore
Livermore
ZHEN

Unicycive Therapeutics, Inc.

UNCY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001766140

No open-market purchases or sales by Unicycive Therapeutics, Inc. insiders were filed in the last 90 days; 79 institutions reported holding it in 13F filings for Q2 2026, worth $54.6M in total; no superinvestor holds it.

Holders of 5% or more of UNCY

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Unicycive Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of UNCY
HolderLatest formStakeChangeFirst filedLatest filingFiling
Vivo Opportunity Fund Holdings, L.P.13G/A9.99%61.0M shares–May 15, 20251 filingMay 15, 2025SEC
Vivo Opportunity Fund Holdings, L.P.13G/A9.99%6.10M shares–Nov 14, 20251 filingNov 14, 2025SEC
Nantahala Capital Management, LLC13G/A9.99%1.86M shares0.00 ppfrom 9.99%Nov 14, 20245 filingsNov 14, 2025SEC
Biotechnology Value Fund L P13G/A9.99%1.42M shares–Aug 14, 20251 filingAug 14, 2025SEC
Ra Capital Management, L.P.13G/A9.90%1.96M shares0.00 ppfrom 9.90%Feb 14, 20253 filingsNov 14, 2025SEC
Octagon Capital Advisors LP13G/A5.70%1.00M shares−2.10 ppfrom 7.80%Aug 12, 20252 filingsNov 14, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

19 Schedule 13D and 13G filings on Unicycive Therapeutics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on UNCY
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 14, 20256:34 PM ETVivo Opportunity Fund Holdings, L.P.and 1 other13G/A9.99%6.10M shares–Sep 30, 2025SEC
Nov 14, 20254:46 PM ETOctagon Capital Advisors LPand 3 others13G/A5.70%1.00M shares−2.10 ppfrom 7.80%Sep 30, 2025SEC
Nov 14, 20254:36 PM ETNantahala Capital Management, LLCand 2 others13G/A9.99%1.86M shares0.00 ppfrom 9.99%Sep 30, 2025SEC
Nov 14, 20254:20 PM ETRa Capital Management, L.P.and 3 others13G/A9.90%1.96M shares0.00 ppfrom 9.90%Sep 30, 2025SEC
Nov 14, 20253:02 PM ETGreat Point Partners LLCand 2 others13G/A4.51%796.6K shares−1.73 ppfrom 6.24%Below 5%Sep 30, 2025SEC
Aug 14, 20255:16 PM ETGreat Point Partners LLCand 2 others13G/A6.24%796.6K shares−3.75 ppfrom 9.99%Jun 30, 2025SEC
Aug 14, 20254:38 PM ETNantahala Capital Management, LLCand 2 others13G/A9.99%1.23M shares0.00 ppfrom 9.99%Jun 30, 2025SEC
Aug 14, 20254:05 PM ETBiotechnology Value Fund L Pand 9 others13G/A9.99%1.42M shares–Jun 30, 2025SEC
Aug 12, 20254:05 PM ETOctagon Capital Advisors LPand 3 others13G/A7.80%1.00M shares–Jun 30, 2025SEC
May 15, 20254:56 PM ETRa Capital Management, L.P.and 3 others13G/A9.90%13.3M shares0.00 ppfrom 9.90%Mar 31, 2025SEC
May 15, 20254:39 PM ETNantahala Capital Management, LLCand 2 others13G/A9.99%12.2M shares0.00 ppfrom 9.99%Mar 31, 2025SEC
May 15, 20258:30 AM ETVivo Opportunity Fund Holdings, L.P.and 1 other13G/A9.99%61.0M shares–Mar 31, 2025SEC
Feb 14, 20256:43 PM ETRa Capital Management, L.P.and 3 others13G/A9.90%11.5M shares–Dec 31, 2024SEC
Feb 14, 20254:39 PM ETGreat Point Partners LLCand 2 others13G/A9.99%11.5M shares–Dec 31, 2024SEC
Feb 6, 20253:08 PM ETWalleye Capital LLC13G/A4.82%5.00M shares–Below 5%Dec 31, 2024SEC
Dec 20, 20244:32 PM ETNantahala Capital Management, LLCand 2 others13G/A9.99%10.9M shares0.00 ppfrom 9.99%Dec 19, 2024SEC
Dec 20, 20244:31 PM ETNantahala Capital Partners Limited Partnership13G/A2.76%3.01M shares−5.00 ppfrom 7.76%Below 5%Dec 19, 2024SEC
Nov 14, 20244:53 PM ETNantahala Capital Partners Limited Partnership13G/A7.76%7.89M shares–Sep 30, 2024SEC
Nov 14, 20244:53 PM ETNantahala Capital Management, LLCand 2 others13G/A9.99%10.2M shares–Sep 30, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Unicycive Therapeutics, Inc. shares.

No Form 144 notices for Unicycive Therapeutics, Inc. are on file.